Accenture announced it is accepting applications for the third annual Accenture HealthTech Innovation Challenge (#HealthTechChallenge on twitter), which aims to improve the way people access and manage healthcare. It brings together startups with health and life sciences companies to tackle some of the world’s greatest health challenges, including access, quality, and affordability-of-care options.
The three categories for the third annual Accenture HealthTech Innovation Challenge are:
Key criteria that applications should address include solution innovation, solution design quality, disruptive business model, potential impact on patient outcomes, and solution scalability.
Emerging healthcare technology innovators and disruptors are encouraged to apply for the program by clicking here now through Sept. 1.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.